L’Oreal invests in Swiss biotech company, Timeline
L’Oreal’s venture capital fund, BOLD has acquired a minority stake in Timeline. The Swiss biotech company has developed a proprietary molecule that is said to recycle and rejuvenate aging mitochondria. Financial terms of the deal were not disclosed.
CLICK HERE